Key Takeaway: Vanda Pharmaceuticals Inc. has announced its participation in the upcoming Mizuho Neuro & Ophthalmology Summit 2025, which will take place in New York City on May 21, 2025. The company plans to engage in investor meetings during this summit, highlighting its strategic focus on neuro and ophthalmology markets. The participation reflects Vanda's commitment to connecting with stakeholders and showcasing its advancements in these fields.
Price reaction · baseline $3.93 (2025-05-15 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close
+5.9%
day 1
+9.7%
day 3 · peak
+9.9%
Market Sentiment Analysis
POSITIVE FACTORS
Vanda Pharmaceuticals is actively engaging with investors.
Participation in a prestigious summit indicates confidence in company prospects.
Opportunity to showcase developments to a targeted audience.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis
Full Press Release Details
WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
Frequently Asked Questions
When is Vanda Pharmaceuticals participating in investor meetings?
Vanda Pharmaceuticals will participate in investor meetings on May 21, 2025.
Where will the Mizuho Neuro & Ophthalmology Summit be held?
The summit will take place in New York City.
Who are the executives mentioned in the press release?
The executives include Jim Golden, Jack Kelleher, and Dan Moore.
What is the Nasdaq ticker symbol for Vanda Pharmaceuticals?
The Nasdaq ticker symbol for Vanda is VNDA.
What type of event is the Mizuho Neuro & Ophthalmology Summit?
It is a summit focused on neuro and ophthalmology sectors.